Supplements · Metabolic & Cardiometabolic
tree nuts decreases LDL cholesterol
In plain terms: Do tree nuts lower bad cholesterol?
Yes, well-established across pooled human trials, though they don't change blood sugar.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Tree nuts (almond, cashew, etc.) lower LDL and ApoB; glycemic parameters are largely unaffected (their per-slice GI benefit is carb-dilution, not intrinsic glucose-lowering). Bakeable & premium-positioned; allergen labeling.
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Nijssen KMR, Chavez-Alfaro MA, Joris PJ, Plat J, Mensink RP 2024 · Nutrients | RCT | tested-null | moderate | Crossover RCT, 28 older overweight/obese adults, 60 g/d mixed tree nuts vs no nuts, 16 wk each (INC-funded; NMR secondary analysis of NCT04210869). Underpowered trend on the claim's object: NMR total LDL-C -0.16 mmol/L (95% CI -0.36 to 0.05), p=0.129 - 'No statistically significant differences were observed for total LDL-C'. Adjacent endpoints did fall: ApoB -0.07 g/L (-0.12 to -0.02), non-HDL-C -0.28 mmol/L (-0.52 to -0.04), LDL particle number -77 nmol/L (-152 to -2). |
| De Lira-García C, Bacardí-Gascón M, Jiménez-Cruz A 2012 · Nutr Hosp | meta-analysis | mixed | low | SR of long-term nut/seed/oil consumption: inconsistent effects on lipids; some LDL reduction, heterogeneous. |
| Nora CL, Zhang L, Castro RJ, Marx A, Carman HB, Lum T, Tsimikas S, Hong MY 2023 · Nutr Metab Cardiovasc Dis | RCT | contradicts | low | 16-week parallel RCT, 29 adults with overweight/obesity: 42.5 g/day mixed nuts (35.5 g tree nuts + 7 g peanuts) vs 69 g/day isocaloric pretzels. 'There were no significant differences in TG, TC, HDL-C, or LDL-C between groups'; Table 2 LDL-C rose in both arms, more with nuts (pretzels 99.7 -> 104.9 mg/dL; nuts 90.7 -> 106.7 mg/dL at week 16) - a clean null pointing away from the claim (no CI reported). Lp(a) also unchanged. Authors: 'no evidence of an effect on LDL-C or Lp(a)'. Small (14-15 per arm, 70% power), normolipidaemic baseline. The earlier extract claiming LDL-C and Lp(a) were lowered misread the paper. |
| Rajaram S, Cofán M, Sala-Vila A, Haddad E, Serra-Mir M, Bitok E, Roth I, Freitas-Simoes TM, Kaur A, Valls-Pedret C, Doménech M, Oda K, Corella D, Sabaté J, Ros E 2021 · Circulation | RCT | supports | high | WAHA 2-yr RCT: daily walnuts lowered LDL-C and improved lipoprotein subclasses in healthy elders. |
| Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, Das A, Hartley L, Stranges S 2019 · Cochrane Database Syst Rev | meta-analysis | mixed | high | Mediterranean diet (nut-inclusive) trials: modest LDL/lipid benefits; nut-specific effect not isolated, evidence limited. |
| Musa-Veloso K, Gauntlett C, Geronimo K, Vicente I, Ho SPL 2025 · Nutrients | meta-analysis | supports | high | SR/MA of RCTs: almond consumption reduces total & LDL cholesterol; ApoB/ApoB:ApoA effects characterized. |
| Lazzarin T, Ballarin RS, Azevedo PS, Cardoso BR, Minicucci MF 2025 · Frontiers in nutrition | observational | supports | low | CKD systematic review (4 studies, n=1270): walnuts reduced LDL cholesterol and blood pressure; moderate-to-high risk of bias in included studies |
| Jia Y, Wang H, Fan W, Lv J, Niu Q, Zhu R, Zhang Q 2024 · Frontiers in nutrition | meta-analysis | mixed | low | MA of 7 CHD studies (n=324): almond intake ↓TC -15.53 mg/dL (95%CI -21.97,-9.1) and ↓LDL -14.62 mg/dL (95%CI -20.92,-8.33), p<0.00001 |
| Guadagni AJ, Paton CM, Cooper JA 2026 · The Journal of nutrition | RCT | supports | moderate | Pecan RCT (n=102): 13%/20% energy-dose groups ↓LDL -12.7 to -12.9 mg/dL vs no change in control/low-dose (P<0.05); dose-dependent, no CI given |
| Jenkins DJA, Kendall CWC, Lamarche B, Banach MS, Srichaikul K, Vidgen E, Mitchell S, Parker T, Nishi S, Bashyam B, de Souza RJ, Ireland C, Pichika SC, Beyene J, Sievenpiper JL, Josse RG 2018 · Diabetologia | RCT | supports | moderate | Replacing dietary carbohydrate with mixed nuts lowered LDL-C and improved CVD risk factors in T2D (reanalysis). |
| Del Gobbo LC, Falk MC, Feldman R, Lewis K, Mozaffarian D 2015 · Am J Clin Nutr | meta-analysis | supports | high | 61-RCT dose-response: tree nuts lower LDL-C, TC, ApoB |
| Guasch-Ferré M, Tessier AJ, Petersen KS, Sapp PA, Tapsell LC, Salas-Salvadó J, Ros E, Kris-Etherton PM 2023 · Nutrients | observational | supports | moderate | Comprehensive review of 19 MAs: total & tree nuts consistently lower LDL-C (-0.09 to -0.26 mmol/L) and TC. |
| Houston L, Probst YC, Chandra Singh M, Neale EP 2023 · Adv Nutr | meta-analysis | supports | moderate | SR/MA of RCTs: tree nut & peanut consumption improves CVD risk factors incl. lowering LDL cholesterol. |
| Martínez-Ortega IA, Mesas AE, Bizzozero-Peroni B, Garrido-Miguel M, Jiménez-López E, Martínez-Vizcaíno V, Fernández-Rodríguez R 2025 · (NMA) | meta-analysis | supports | high | NMA 76 RCTs: all nuts benefit >=1 lipid (cashew best LDL); glycemic params unaffected |
| Liu K, Hui S, Wang B, Kaliannan K, Guo X, Liang L 2020 · Am J Clin Nutr | meta-analysis | supports | high | network MA: all tree-nut types reduce LDL-C/TC |
| Vilela DLS, Silva AD, Pelissari Kravchychyn AC, Bressan J, Hermsdorff HHM 2024 · Foods (Basel, Switzerland) | meta-analysis | tested-null | low | MA of 10 RCTs, nuts (28-84g/d) added to energy-restriction diets: no differential effect on LDL-c vs control (null in ER context) |
| Wong HY, Coates AM, Carter S, Hill AM 2025 · Nutrition reviews | meta-analysis | supports | moderate | MA of 115 RCTs (109 meta-analyzed): nut consumption significantly reduced LDL-C, TC, VLDL-C, non-HDL-C, ApoB; no effect on HDL-C or BP |
| Hadi A, Asbaghi O, Kazemi M, Haghighian HK, Pantovic A, Ghaedi E, Abolhasani Zadeh F 2023 · Crit Rev Food Sci Nutr | meta-analysis | supports | high | SR/MA of 12 RCTs: pistachio consumption lowered TC, LDL-C and TG in adults. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.